Cargando…
Molecular mechanism of Epimedium in the treatment of vascular dementia based on network pharmacology and molecular docking
Backgroud: Vascular dementia is the second most common cause of dementia after Alzheimer’s disease, accounting for an estimated 15% of cases. Recently, Epimedium has attracted great attention for its potential neuroprotective benefit. However, the direct role and mechanism of Epimedium on vascular d...
Autores principales: | Xie, Chenchen, Tang, Hao, Liu, Gang, Li, Changqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424771/ https://www.ncbi.nlm.nih.gov/pubmed/36051307 http://dx.doi.org/10.3389/fnagi.2022.940166 |
Ejemplares similares
-
Integration of network pharmacology and molecular docking to explore the molecular mechanism of Cordycepin in the treatment of Alzheimer’s disease
por: Ma, Xiaoying, et al.
Publicado: (2022) -
Mechanism of Epimedium intervention in heart failure based on network pharmacology and molecular docking technology
por: Boyang, Chen, et al.
Publicado: (2022) -
Molecular Mechanism of Epimedium Extract against Ischemic Stroke Based on Network Pharmacology and Experimental Validation
por: Xu, Hongbei, et al.
Publicado: (2022) -
Efficacy of acupuncture and pharmacological therapies for vascular cognitive impairment with no dementia: a network meta-analysis
por: Li, Ruiyu, et al.
Publicado: (2023) -
Network Pharmacology-Based Strategy to Investigate the Pharmacologic Mechanisms of Coptidis Rhizoma for the Treatment of Alzheimer's Disease
por: Ye, Xian-wen, et al.
Publicado: (2022)